Introduction
The glyoxalase system catalyses the conversion of methyiglyoxal tO D-lactic acid, via the intermediate S-Dlactoylgiutathione (Racker, 1951) . There are two constituent enzymes: glyoxalase I (E.C. 4.4.1.5), a dimeric protein which catalyses the formation of S-D-lactoylglutathione from methyiglyoxal and reduced glutathione MeCOCHO +GSH Glyoxalasel MeCH(OH) CO-SG and glyoxalase II (E.C. 3.1.2.6), a monomeric protein that catalyses the hydrolysis of S-D-lactoylglutathione to D-lactate, regenerating reduced glutathione
MeCH(OH)CO-SG + H20
Glyoxalase 1
MeCH(OH)CO2H + GSH
Recent investigations of the glyoxalase system have suggested that there may be characteristic activities of glyoxalase enzymes associated with the development of clinical complications in insulin-dependent diabetes mellitus (Thornalley et al., 1989) , and glyoxalase activity may be a predisposition factor for developing complications should an individual develop the disease (Thornalley, 1990) . The genetics and polymorphism of glyoxalase have also been investigated in diabetes mellitus and associated clinical complications. There is considerable variation in the population genetics of glyoxalase with geographical location. This provides an opportunity to investigate the correlation of glyoxalase allele and phenotype frequencies with the incidence of diabetes mellitus and its susceptibility to complications.
This report describes the genetic characteristics of glyoxalase I and II, surveys the variation of allele frequency with geographical location and assesses the association of glyoxalase with the incidence of diabetes mellitus and associated complications.
Genetics of glyoxalase I
Human glyoxalase I was found to exhibit genetic polymorpism originally in red blood-cells (Kompf et al., 1975a) . There were three phenotypes Gb 1-1, Gb 1-2 and Gb 2-2, representing the homozygous and heterozygous expression of a two allelic gene, Gb1 and Gb2 (Kompf et a!., 197 Sb) . An analogous phenotypic expression was found in 23 different human tissues in each of 49 autopsies (Stohlmacher & Haferland, 1980) . The Gb alleles are inherited autosomally in a codominant manner. The Gb locus has been assigned to chromosome 6 by somatic-cell hybridization (Bender & Grzeschik, 1976) , and to the major histocompatibiity complex by linkage analysis (Kompf et ab., 1976). Gb lies between the centromere and HLA-DR; the meiotic distance between HLA-DR is -6 cM (Bakker eta!., 1979; Leach etal., 1986) .
The allele frequencies of Gb in geographically Glyoxalase I is not polymorphic in closely-related hominoid species, e.g. Pan troglodytes -the chimpanzee (Payne et al., 1982) . The electrophoretic mobility of glyoxalase I in the chimpanzee was found to be identical to the human Gb 2-2 phenotype. The Gb2 allele has been proposed to be the ancestral allele with the Gb' allele arising by mutation. The geographical distribution of Gb' allele-frequency is consistent with this mutation occurring in North America or there being some environmental advantage for the Gb' allele in North American and West European population.
Polymorphism of glyoxalase I in diabetes mellitus
Polymorphism of glyoxalase I has been described in five independent surveys of diabetic patients and normal, healthy controls. There was no significant difference in Gb' allele-frequency between these two groups. The distribution, however, of GLO phenotypes was disturbed.
For insulin-dependent diabetes mellitus (IDDM)
there was a significant disturbance in GLO phenotype distribution: an increase in Gb 1-1 homozygote (McCann et al., 1981; Cambdon de Mouzon et al., 1982) or an increase in Gb 1-2 heterozygote (Kirk et ab., 1985) . Other surveys (Allannic et al., 1985; Kirk et al., 1979) found no significant difference between IDDM patients and controls. The present paper reports an investigation of the relationship between geographical variation in glyoxalase I genotype and the incidence of IDDM for 10 countries, using the recently collated data of LaPorte et al. (1985) , and the corresponding Gb '-genotype data obeying the Hardy-Weinberg principle. No significant correlation was found using the Kendall Rank-correlationcoefficient analysis between the incidence of IDDM and Gb1 allele-frequency or Gb-genotype distribution (Z= 0.447, Fig. 2 ).
For non-insulin-dependent diabetes mellitus (NIDDM), a disturbance in the GLO-phenotype distribution has also been reported (Kirk et ab., 1979) , associated with an increase in the Gb 2-2 phenotype, but this was not confirmed (Kirk et a!., 1985; McCann et al., 1981) .
Diabetic patients suffer chronic complications (retinopathy, cataract, peripheral neuropathy, nephropathy and generalized microangiopathy). No genetic link with the development of complications has yet been established. There has only been one survey relating the development of retinopathy and neuropathy to GLO phenotypes. Here, IDDM patients without complications (retinopathy, neuropathy) had a significant excess of the homozygote Gb 1-i compared to Relevance of glyoxalase genetics to diabetes Fig. 2 Geographical population incidence of insulindependent diabetes mellitus (IDDM) and Gb' allelefrequency. IDDM incidence was taken from LaPorte et al. (1985) . Gb' frequency was calculated from reports of similar ethnic composition to the diabetes incidence data normal healthy controls (McCann et al., 1981) . It was also in IDDM patients that characteristic activities of red-blood-cell glyoxalases were found for patients with or without complications (Thornalley et al., 1989) .
International comparisons of Gb' allele-frequency and susceptibility to complications are made with caution since the diagnosis and clinical management may vary. Cumulative survival-rates for IDDM patients may give an indication of the severity of complications. Data are available for Finland, USA, Israel and Japan -countries with well developed primary health care services. Survival rates are very similar for Finland, ) but very much lower in Japan (0.898) (LaPorte, 1990) . It is of interest that the Gb' frequencies for Finland (0.358), USA (0.379) and Israel (0.306) are also similar, whereas Gb' frequency in Japan is very much lower (0.067). Hence, a deficiency in Gb' allele may be associated with the occurrence of diabetic complications and high mortality.
Genetics of glyoxalase II
The gene for glyoxalase II humans (HAGH) is on chromosome 16 (Honey & Shows, 1981) . There is usually only one phenotype expressed, although a rare second form (frequency 0.016) was found in a Micronesian population (Board, 1980; Sugita & Takahama, 1983) . Glyoxalase-Il polymorphism occurs in other species. A survey of 10 anthropoid primates indicated a high degree of polymorphism of erythrocyte glyoxalase II (Board et al., 1981) . The disturbance of glyoxalase II phenotypes in diabetes has not yet been investigated.
Genetic susceptibility markers for IDDM have been suggested (Todd et al., 1987; Morel et al., 1988) . The nature of the genetic contribution to the aetiology of NIDDM remains obscure (Jarrett, 1989) . There was no correlation between the incidence of IDDM and glyoxalase I allele-frequency, and disturbances in glyoxalase I phenotypes in IDDM and NIDDM have not been generally confirmed. There is a suggestion, however, that IDDM patients with or without chronic clinical complications have characteristic phenotypefrequencies (McCann et al., 1981) and glyoxalase activities (Thornalley et al., 1989) . The implication of an involvement of glyoxalases in the development of complications is a novel approach (Thornalley, 1990) and genetic aspects of this require further investigation.
